Data-Driven Sterile Compounding
Planned in cooperation with the ASHP SICP Educational Steering Committee + SAG on Compounding Practice
ACPE Activity Number: 0204-0000-23-034-H07-P/T
Release Date: 1/24/2023
Expiration Date: 1/24/2026
Activity Type: Knowledge-based
CE Credits: 1.0 contact hour, (0.10 CEU)
Activity Fee: Member – Free / Non-Member – Not Available
This activity is a recording from a live webinar and those that claim credit for the live webinar should not claim credit for this activity.
Activity Overview
This webinar will begin with an introduction into sterile compounding including USP revisions and technology available to assist with ensuring compliance. Use of task-driven workflows and sterile compounding compliance monitoring will be described from one institution’s perspective. The webinar will review how IV workflow software accounts for time of tasks and compliance of gravimetric usage. Additionally, examples will be provided of dashboard items to report to applicable committees and leadership.
Accreditation
The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
Target Audience
Learning Objectives
After completing this activity, the learner should be able to…
1. Identify basic components of USP 797 that can be accomplished and tracked through technology.
2. Describe how to use software to track cleaning and monitoring activities.
3. List the advantages of IV workflow software to enhance medication safety practices in sterile compounding.
Schedule of Activities
-
Introduction and Announcements
-
Presentation
-
Questions, Answers, and Discussion
Faculty
PGY2 HSPAL Resident
University of Michigan Health
Ann Arbor, MI
Jeffrey Pilz, PharmD, MPA, MS, BCPS
Assistant Director of Pharmacy - Medication Safety and Drug Policy
The Ohio State University Wexner Medical Center
Columbus, OH
Bridget Gegorski, PharmD, MS, BCSCP
Medication Safety Officer, Manager; Medication Safety Department
University Hospitals Health System
Cleveland, OH
Moderator:
Maria Bowen, PharmD
Medication Safety & Drug Information Specialist
University Hospitals Health System
Cleveland, OH
Relevant Financial Relationship Disclosure
In accordance with our accreditor’s Standards of Integrity and Independence in Accredited Continuing Education, ASHP requires that all individuals in control of content disclose all financial relationships with ineligible companies. An individual has a relevant financial relationship if they have had a financial relationship with an ineligible company in any dollar amount in the past 24 months and the educational content that the individual controls is related to the business lines or products of the ineligible company.
An ineligible company is any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. The presence or absence of relevant financial relationships will be disclosed to the activity audience.
-
No one in control of the content of this activity has a relevant financial relationship (RFR) with an ineligible company.
Methods and CE Requirements
This activity consists of recordings of faculty slides presentations, active learning activities, discussion, and handouts. Participants must participate in the activity in its entirety to claim continuing pharmacy education credit online at ASHP Learning Center. Follow the prompts online to complete the evaluation, claim credit and view the statement of credit immediately after completing the activity.
Per ACPE requirements, CPE credit must be claimed within 60 days of being earned. Once you have processed and claimed your CE credit, we encourage you to check your NABP eProfile account to verify your credits were transferred successfully before the ACPE 60-day deadline. It is an electronic direct-report process so your credits should appear in your account within a few minutes. After the 60 day deadline, ASHP will no longer be able to report your credit(s) for this activity.